Functional studies further confirmed that miR-146a is a negative regulator of tumorigenic gene expression in microglia via its target SMAD4, as its overexpression in microglia resulted in suppression of MMP9, which is a tumorigenic factor that promotes migration of microglia towards GCM and the glioma viability in vitro. This evidence concerns the gene MMP9 and central nervous system cancer.